Vol 17 (2010)

Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective



Table of Contents

Prostate Cancer Supplement 2010

Management of prostate cancer: Canadian contribution to the changing landscape PDF
F. Saad S3
Prevention strategies in prostate cancer PDF
G. Trottier, N. Lawrentschuk, N.E. Fleshner S4-S10
Active surveillance for prostate cancer: patient selection and management PDF
L. Klotz S11-S17
Radiation therapy in prostate cancer: a risk-adapted strategy PDF
A. J. Hayden, C. Catton, T. Pickles S18-S24
Role of surgery in high-risk localized prostate cancer PDF
N. Lawrentschuk, G. Trottier, C. Kuk, A. R. Zlotta S25-S32
Multimodal approaches to high-risk prostate cancer PDF
A. Koupparis, M.E. Gleave S33-S37
Androgen deprivation therapy for prostate cancer—review of indications in 2010 PDF
H. Quon, D.A. Loblaw S38-S44
Intermittent versus continuous androgen suppression therapy: do we have consensus yet? PDF
N. C. Buchan, S. L. Goldenberg S45-S48
Bone health in nonmetastatic prostate cancer: what’s the big deal? PDF
J.B. Lattouf, F. Saad S49-S54
Cardiac and cognitive effects of androgen deprivation therapy: are they real? PDF
S. M.H. Alibhai, H. Z. Mohamedali S55-S64
Preventing bone complications in advanced prostate cancer PDF
M. A. Luz, A. G. Aprikian S65-S71
Current management of castrate-resistant prostate cancer PDF
S. J. Hotte, F. Saad S72-S79
Research in castration-resistant prostate cancer: what does the future hold? PDF
R. J. Macfarlane, K. N. Chi S80-S86





Copyright © 2012 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)